Our previous study revealed that CELF1 exerts its influence by modulating the LIP/LAP molar ratio, thereby controlling the diverse mRNA splicing profiles of INSR in breast cancer cells and affecting cell aggressiveness (Huang et al., 2020). Here, CEBPB is linked to breast carcinoma.